Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|Pluristem and U.S. Department of Defense...||07/17/19|
|The animal studies, conducted following guidance from the U.S. Food and Drug Administration (FDA) relating to its animal rule pathway, are designed to...|
|Pluristem Therapeutics’ CEO Issues Share...||07/02/19|
|Pluristem Therapeutics Inc. (PSTI) (PSTI.TA), a leading regenerative medicine company developing novel placenta-based cell therapy products, today iss...|
|Date||2019-07-23 (BMO)||Est. (EPS/Rev.)||($0.06)/ 0|
|Actual (EPS/Rev.)||/||EPS (TTM)||0|